MPJE Acts & Statutes Practice Test

Question 1 of 3
85% Get this Question Right
The Biologics Price Competition and Innovation Act of 2010
mandated accurate product labeling with standards of strength, quality and purity.
The Omnibus Budget Reconciliation Act of 1990
True generics for biologics are not possible, so the term biosimilars were created creating an approval process for them. (Zarxio, biosimilar for Neupogen was the frsrt approved in 2015).
Expedited and streamlined generic drug approvals via an ANDA or 505b2